Next Article in Journal
Development of a Medication-Related Osteonecrosis of the Jaw Prediction Model Using the FDA Adverse Event Reporting System Database and Machine Learning
Next Article in Special Issue
Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis
Previous Article in Journal
Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management
Previous Article in Special Issue
Cardioprotective Effects of Ferulic Acid Through Inhibition of Advanced Glycation End Products in Diabetic Rats with Isoproterenol-Induced Myocardial Infarction
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(3), 422; https://doi.org/10.3390/ph18030422
Action Date Notes Link
article xml file uploaded 17 March 2025 09:45 CET Original file -
article xml uploaded. 17 March 2025 09:45 CET Update -
article pdf uploaded. 17 March 2025 09:45 CET Version of Record -
article html file updated 17 March 2025 09:47 CET Original file -
article xml file uploaded 17 March 2025 10:48 CET Update -
article xml uploaded. 17 March 2025 10:48 CET Update https://www.mdpi.com/1424-8247/18/3/422/xml
article pdf uploaded. 17 March 2025 10:48 CET Updated version of record https://www.mdpi.com/1424-8247/18/3/422/pdf
article html file updated 17 March 2025 10:51 CET Update https://www.mdpi.com/1424-8247/18/3/422/html
Back to TopTop